Description
This variant is denoted ATM c.2666A>G at the cDNA level, p.Tyr889Cys (Y889C) at the protein level, and results in the change of a Tyrosine to a Cysteine (TAT>TGT). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. ATM Tyr889Cys was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Since Tyrosine and Cysteine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. ATM Tyr889Cys occurs at a position that is poorly conserved across species and is not located in a known functional domain. In silico analyses predict that this variant is unlikely to alter protein structure or function (UniProt). Based on currently available information, it is unclear whether ATM Tyr889Cys is pathogenic or benign. We consider it to be a variant of uncertain significance.
| # | Sample | Method | Observation |
|---|
| Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
|---|
| 1 | germline | yes | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |
